SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001214659-22-011929
Filing Date
2022-10-04
Accepted
2022-10-04 16:06:03
Documents
47
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 r9282206ka1.htm   iXBRL 6-K/A 515398
  Complete submission text file 0001214659-22-011929.txt   2512419

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mtp-20220630.xsd EX-101.SCH 27840
3 XBRL CALCULATION FILE mtp-20220630_cal.xml EX-101.CAL 39214
4 XBRL DEFINITION FILE mtp-20220630_def.xml EX-101.DEF 55539
5 XBRL LABEL FILE mtp-20220630_lab.xml EX-101.LAB 173856
6 XBRL PRESENTATION FILE mtp-20220630_pre.xml EX-101.PRE 145308
41 EXTRACTED XBRL INSTANCE DOCUMENT r9282206ka1_htm.xml XML 415024
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Midatech Pharma Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-37652 | Film No.: 221291507
SIC: 2834 Pharmaceutical Preparations